Vynleads Inc (VYND) is a digital health company that operates the Done With Diabetes app, a subscription-based lifestyle wellness platform targeting adults with type 2 diabetes, prediabetes, and related metabolic health conditions. Revenue comes primarily from direct-to-consumer subscriptions priced at $29 per month following a seven-day free trial, as of the filing date of the FY2025 10-K (filed 2026-03-31). The company also historically generated revenue from discrete digital wellness products, newsletters, and nutritional supplements, though its principal focus has shifted to the app-based subscription platform. Vynleads was incorporated in Delaware in July 2015 and introduced the Done With Diabetes brand in 2016. CEO Alex J. Mannine serves as principal executive, financial, and accounting officer. The company reported net losses of $255,066 in FY2025 and $261,192 in FY2024, an accumulated deficit of $3,040,596 as of December 31, 2025, and a working capital deficit of $352,431. Its auditors have raised substantial doubt about its ability to continue as a going concern.

Revenue model

Direct-to-consumer subscriptions at $29 per month (seven-day free trial) via the Done With Diabetes app. Historical revenue sources include discrete digital wellness products, newsletters, and nutritional supplements. The company intends to pursue enterprise distribution channels, which may include per-participant fees, program access fees, implementation fees, and reporting services, though none of these enterprise arrangements had been established as of the FY2025 10-K filing.

Products and services

Done With Diabetes: an app-based, 56-day structured wellness program built around four sequential phases (Foundation, Meal Plan, Lifestyle, and Control), incorporating daily missions, meal guidance, dashboards, community features, AI coaching, and gamified engagement tools. Brand portfolio includes Vynleads, Done With Diabetes, Lifestyle Blueprint, and Dr. Smith AI Coach, together with related content libraries and software logic (per FY2025 10-K). The company has discussed a broader DWX platform vision that could extend to additional condition-specific programs, including heart disease and depression, though these remain unrealized.

Customers and end markets

Direct-to-consumer: adults with type 2 diabetes, prediabetes, and related metabolic health goals. Prospective enterprise customers include employers, health plans, and wellness program sponsors, though enterprise revenue had not been established as of the filing date. No customer concentration data was disclosed in the excerpts.

Value-chain role

App developer and direct-to-consumer platform operator in the digital health and metabolic wellness segment. The company relies on third-party consultants, contractors, and service providers for operational, development, finance, marketing, and support functions, given its very limited internal headcount as of the filing date.

Competitors

Digital health and wellness applications (unnamed), Nutrition and habit-tracking products (unnamed), Diabetes education services (unnamed), Weight-management platforms (unnamed), General health content publishers (unnamed), Broader enterprise wellness vendors (unnamed), Digital condition-management platforms (unnamed)

Source: SEC 10-K, filed 2026-03-31

Industry: Services-Personal Services